NPI: 1629218185 · SPARKS, NV 89434 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,031 | $293K |
| 2019 | 14,850 | $294K |
| 2020 | 17,613 | $422K |
| 2021 | 18,221 | $472K |
| 2022 | 20,713 | $462K |
| 2023 | 18,759 | $494K |
| 2024 | 8,047 | $459K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 47,822 | 2,227 | $2.89M | |
| Q4081 | Epoetin alfa, 100 units esrd | 27,480 | 1,007 | $3K |
| J1270 | Injection, doxercalciferol | 14,635 | 831 | $139.32 |
| G0008 | Admin influenza virus vac | 137 | 69 | $49.62 |
| 90661 | 18 | 18 | $36.85 | |
| 83970 | 1,627 | 708 | $0.00 | |
| 85041 | 2,565 | 1,128 | $0.00 | |
| J1756 | Iron sucrose injection | 8,056 | 1,269 | $0.00 |
| 83540 | 1,130 | 501 | $0.00 | |
| 85048 | 2,534 | 1,115 | $0.00 | |
| J0887 | Epoetin beta esrd use | 354 | 167 | $0.00 |
| 85045 | 596 | 213 | $0.00 | |
| 82108 | 135 | 58 | $0.00 | |
| A4657 | Syringe w/wo needle | 3,955 | 1,322 | $0.00 |
| 82728 | 1,116 | 502 | $0.00 | |
| 83550 | 599 | 312 | $0.00 | |
| G0499 | Hepb screen high risk indiv | 326 | 71 | $0.00 |
| 82306 | 149 | 70 | $0.00 |